| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 2 | 3 | 3 | 6 | 6 | 12 | 12 | 11 | 15 | 15 | 18 | 19 |
| Expenses | 2 | 2 | 2 | 5 | 6 | 11 | 11 | 10 | 13 | 13 | 16 | 18 |
| EBITDA | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Operating Profit % | -12 % | -1 % | -19 % | -2 % | 7 % | 6 % | 1 % | -9 % | 4 % | 5 % | 3 % | 4 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 1 | 0 | -0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 2 | 0 | 0 | 1 |
| EPS in ₹ | 0.01 | 0.00 | 0.03 | 0.20 | 0.23 | 0.46 | 0.55 | -0.11 | 1.52 | 0.21 | 0.20 | 0.20 |
Veerhealth Care
Veerhealth Care
17.55
-0.16
(-0.90%)
Key Fundamentals
Market Cap
35.08 Cr
EPS
0.20
PE Ratio
77.00
Dividend Yield
0.00 %
Industry
Healthcare 52 Week High
23.77
52 Week Low
9.29
PB Ratio
1.56
Debt to Equity
0.11
Sector
Pharmaceuticals Actual
Company News
View All News
Veerhealthcare Limited Reports Quarterly Results and Company Secretary Resignation6 days ago
Veerhealthcare Limited's Board approved unaudited financial results for the quarter and half year ended September 30, 2025. The company reported total revenue of Rs 7.05 lakhs for the quarter, with a net profit of Rs 25.22 lakhs. For the half year, total revenue was Rs 14.10 lakhs with net profit of Rs 50.28 lakhs. The Board also accepted the resignation of Mr. Rony Mukesh Shah from his position as Company Secretary and Compliance Officer. The company operates in a single segment of Healthcare Pharma Products. Basic earnings per share for the quarter was Rs 0.13 and Rs 0.25 for the half year.
Veerhealth Care Limited announced it has received an order worth Rs 1.70 crores from a company with a top position in the personal care segment on marketplace companies. The order involves manufacturing and supply of face care products for the client's private-label personal care range. The company must execute the order within 30 days. The order comes from a domestic entity, and the client's name remains undisclosed due to confidential terms. Veerhealth Care expects this order to represent a significant opportunity and anticipates additional growth in turnover.
Veerhealth Care Secures Rs 0.78 Crore Hair Care Products Order from Leading Pharmacy Chain
Oct 28, 2025
Oct 28, 2025Veerhealth Care Limited received an order worth Rs 0.78 crores from one of India's leading pharmacy chains for manufacturing and supply of hair care products. The customer operates over 5,000 retail pharmacy outlets and has the largest retail pharmacy network in India. The order is to be executed within 30 days and involves a domestic entity. The company anticipates additional growth in turnover from this new order. The transaction does not involve any related party dealings or promoter group interests.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,784.10 | #1 4,28,065.35 | 40.27 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 74.53 | |
6,454.00 | 1,71,333.42 | 69.17 | 9,712.00 | 18.67 | 2,191 | 35.10 | 46.81 | |
3,731.40 | 1,26,287.53 | 59.99 | 11,539.40 | 6.99 | 1,911 | 30.46 | 56.17 | |
1,526.80 | 1,23,327.89 | 22.52 | 28,409.50 | 7.12 | 5,291 | 3.71 | 47.29 | |
1,250.20 | 1,04,343.41 | #1 18.09 | 33,741.20 | 16.73 | 5,725 | -0.38 | 54.25 | |
930.20 | 93,599.89 | 18.57 | 23,511.00 | 18.55 | 4,615 | 34.60 | 33.90 | |
2,025.40 | 92,511.06 | 21.51 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 57.78 | |
2,223.10 | 91,760.34 | 51.75 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 29.21 | |
1,235.80 | 71,775.46 | 21.23 | 32,345.60 | 9.43 | 3,484 | 3.81 | 74.03 | |
5,724.00 | 68,439.01 | 28.33 | 13,458.30 | 3.70 | 2,216 | 10.98 | 64.07 |
Growth Rate
Revenue Growth
22.60 %
Net Income Growth
-
Cash Flow Change
-113.45 %
ROE
-5.38 %
ROCE
-49.90 %
EBITDA Margin (Avg.)
-31.41 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 14 | 14 | 13 | 15 | 16 | 18 | 19 | 20 | 25 | 28 | 34 |
| Fixed Assets | 2 | 3 | 3 | 6 | 6 | 10 | 10 | 11 | 12 | 12 | 20 |
| Current Assets | 8 | 7 | 8 | 7 | 3 | 6 | 7 | 6 | 10 | 14 | 11 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 12 | 11 | 11 | 9 | 9 | 9 | 9 | 10 | 13 | 16 | 14 |
| Total Liabilities | 14 | 14 | 13 | 15 | 16 | 18 | 19 | 20 | 25 | 28 | 34 |
| Current Liabilities | 1 | 1 | -0 | 1 | 3 | 2 | 2 | 3 | 1 | 3 | 4 |
| Non Current Liabilities | 1 | 1 | 1 | 0 | 0 | 3 | 3 | 4 | 3 | 4 | 8 |
| Total Equity | 13 | 13 | 13 | 13 | 13 | 14 | 14 | 14 | 21 | 22 | 22 |
| Reserve & Surplus | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 11 | 2 | 2 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 10 | 20 | 20 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | -0 | 0 | 0 | -0 | 0 | 0 | 3 | -3 | 1 |
| Investing Activities | 4 | 0 | -0 | -3 | -2 | -2 | -0 | -1 | -2 | -0 | -8 |
| Operating Activities | -4 | 0 | 2 | 2 | 2 | -0 | 1 | 2 | -1 | 3 | -0 |
| Financing Activities | 0 | 0 | -1 | 1 | 0 | 2 | -1 | -0 | 6 | -6 | 10 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 41.92 % | 41.92 % | 41.93 % | 41.93 % | 42.34 % | 44.31 % | 44.36 % | 44.36 % | 30.76 % | 30.76 % | 30.76 % | 30.76 % | 30.41 % | 30.41 % | 30.41 % | 30.41 % | 31.50 % | 31.50 % | 31.50 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 48.78 % | 48.53 % | 48.11 % | 47.50 % | 47.42 % | 44.95 % | 37.12 % | 47.81 % | 55.14 % | 58.28 % | 56.23 % | 56.80 % | 60.05 % | 59.25 % | 58.57 % | 58.53 % | 58.35 % | 57.92 % | 56.97 % |
| Others | 9.29 % | 9.55 % | 9.96 % | 10.57 % | 10.24 % | 10.73 % | 18.52 % | 7.83 % | 14.10 % | 10.96 % | 13.01 % | 12.44 % | 9.54 % | 10.33 % | 11.02 % | 11.06 % | 10.15 % | 10.58 % | 11.53 % |
| No of Share Holders | 3,528 | 3,517 | 3,483 | 3,462 | 3,642 | 3,566 | 3,589 | 3,655 | 3,605 | 3,616 | 6,195 | 6,874 | 10,991 | 10,255 | 11,489 | 11,469 | 11,390 | 11,011 | 10,846 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 22 Sept 2023 |  Bonus | 1:1 | 22 Sept 2023 | 40.72 | 41.24 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 22.37 | 22.09 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 19.97 | 18.24 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 18.51 | 17.21 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 13.19 | 15.21 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 22.13 | 21.94 |
| 30 Sept 2025 | Annual General Meeting | NA | 30 Sept 2025 | 21.94 | 18.02 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 18.15 | 17.73 |
Announcements
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer7 days ago
7 days agoResults-Financial Results For September 30 20257 days ago
7 days agoBoard Meeting Outcome for Outcome Of Board Meeting7 days ago
7 days agoBoard Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter And Half Year Ended 30Th September 2025.Nov 05, 2025
Nov 05, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderNov 01, 2025
Nov 01, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderOct 28, 2025
Oct 28, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderOct 18, 2025
Oct 18, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Oct 07, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderOct 01, 2025
Oct 01, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Oct 01, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Sep 30, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderSep 17, 2025
Sep 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 05, 2025
Sep 05, 2025Reg. 34 (1) Annual Report.Aug 22, 2025
Aug 22, 2025Shareholder Meeting - AGM On September 30 2025Aug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderAug 21, 2025
Aug 21, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 13, 2025
Aug 13, 2025Results-Financial Results For June 30 2025Aug 12, 2025
Aug 12, 2025Board Meeting Outcome for Outcome Of Board MeetingAug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderAug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 04, 2025
Aug 04, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2025.Aug 01, 2025
Aug 01, 2025UpdatesJul 29, 2025
Jul 29, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 25, 2025
Jul 25, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 22, 2025
Jul 22, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJul 21, 2025
Jul 21, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 09, 2025
Jul 09, 2025Announcement Under Regulation 30 (LODR) - Contract Manufacturing Agreement With Leading Marketplace CompanyJul 07, 2025
Jul 07, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 04, 2025
Jul 04, 2025Closure of Trading WindowJun 25, 2025
Jun 25, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 17, 2025
Jun 17, 2025Announcement Under Regulation 30 (LODR) - "Ayuveer" Products Now Available On Myntra For PurchaseJun 16, 2025
Jun 16, 2025Announcement Under Regulation 30 (LODR) - Appointment Of Internal And Secretarial AuditorMay 30, 2025
May 30, 2025Results-Financial Results For March 31 2025May 30, 2025
May 30, 2025Board Meeting Outcome for Outcome Of Board MeetingMay 30, 2025
May 30, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 22, 2025
May 22, 2025Board Meeting Intimation for Consideration And Approval Of Audited Financial Results Of The Company For The Quarter And Financial Year Ended 31St March 2025 And Recommendation Of Dividend If Any.May 21, 2025
May 21, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 20, 2025
May 20, 2025Announcement Under Regulation 30 (LODR) - Successful Closure Of USFDA Inspection Under 21 CFR 20.64(D)(3)May 16, 2025
May 16, 2025Compliances-Compliance Certificate For The Period Ended March 31 2025Apr 04, 2025
Apr 04, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2025
Apr 04, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 07, 2025
Mar 07, 2025Integrated Filing (Financial)Feb 12, 2025
Feb 12, 2025Results-Financial Results For December 31 2024Feb 12, 2025
Feb 12, 2025Board Meeting Outcome for Outcome Of Board MeetingFeb 12, 2025
Feb 12, 2025Technical Indicators
RSI(14)
Neutral 40.09
ATR(14)
Volatile 0.85
STOCH(9,6)
Neutral 32.53
STOCH RSI(14)
Oversold 5.52
MACD(12,26)
Bearish -0.01
ADX(14)
Weak Trend 15.07
UO(9)
Bearish 41.15
ROC(12)
Downtrend And Accelerating -1.96
WillR(14)
Oversold -81.04
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
